Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation

References

1. Balthesen M., Messerle M., Reddehase M. J. 1993; Lungs are a major organ site of cytomegalovirus latency and recurrence. Journal of Virology 67:5360–5366
   [Google Scholar]
2. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. 1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548–550
   [Google Scholar]
3. Dobonici M., Podlech J., Steffens H. -P., Maiberger S., Reddehase M. J. 1998; Evidence against a key role for transforming growth factor- p1 in cytomegalovirus-induced bone marrow aplasia. Journal of General Virology 79:867–876
   [Google Scholar]
4. Ebeling A., Keil G. M., Knust E., Koszinowski U. H. 1983; Molecular cloning and physical mapping of murine cytomegalovirus DNA. Journal of Virology 47:421–433
   [Google Scholar]
5. Einsele H., Hebart H., Bokemeyer C., Kanz L., Jahn G., Müller C. A. 1998; Cytomegalovirus infection following hematopoietic stem cell transplantation. Monographs in Virology 21:106–118
   [Google Scholar]
6. Holt P. G., Degebrodt A., Venaille T., O’Leary C., Krska K., Flexman J., Farrell H., Shellam G., Young P., Penhale J., Robertson T., Papadimitrio J. M. 1985; Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 54:139–147
   [Google Scholar]
7. Jonjić S., Mütter W., Weiland F., Reddehase M. J., Koszinowski U. H. 1989; Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. Journal of Experimental Medicine 169:1199–1212
   [Google Scholar]
8. Jonjić S., Pavić I., Lučin P., Rukavina D., Koszinowski U. H. 1990; Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. Journal of Virology 64:5457–5464
   [Google Scholar]
9. Jonjić S., Pavić I., Polic B., Crnković I., Lučin P., Koszinowski U. H. 1994; Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179:1713–1717
   [Google Scholar]
10. Kesari S., Lasner T. M., Balsara K. R., Randazzo B. P., Lee V. M. -Y., Trojanowski J. Q., Fraser N. W. 1998; A neuroattenuated ICP34.5- deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system. Journal of General Virology 79:525–536
    [Google Scholar]
11. Koszinowski U. H., Reddehase M. J., Jonjić S. 1993; The role of T- lymphocyte subsets in the control of cytomegalovirus infection. In Viruses and the Cellular Immune Response pp 429–445 Thomas D. B. Edited by New York: Marcel Dekker;
    [Google Scholar]
12. Lathbury L. J., Allan J. E., Shellam G. R., Scalzo A. A. 1996; Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. Journal of General Virology 77:2605–2613
    [Google Scholar]
13. Lučin P., Jonjić S., Messerle M., Polić B., Hengel H., Koszinowski U. H. 1994; Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. Journal of General Virology 75:101–110
    [Google Scholar]
14. Mayer A., Podlech J., Kurz S., Steffens H. -P., Maiberger S., Thalmeier K., Angele P., Dreher L., Reddehase M. J. 1997; Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. Journal of Virology 71:4589–4598
    [Google Scholar]
15. Mutter W., Reddehase M. J., Busch F. W., Bühring H. -J., Koszi-nowski U. H. 1988; Failure in generating hematopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. The Journal of Experimental Medicine 167:1645–1658
    [Google Scholar]
16. Pavić I., Polić B., Crnković I., Lučin P., Jonjić S., Koszinowski U. H. 1993; Participation of endogenous tumour necrosis factor a in host resistance to cytomegalovirus infection. Journal of General Virology 74:2215–2223
    [Google Scholar]
17. Polić B., Jonjić S., Pavić I., Crnković I., Zorica I., Hengel H., Lučin P., Koszinowski U. H. 1996; Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo . Journal of General Virology 77:217–225
    [Google Scholar]
18. Rawlinson W. D., Farrell H. E., Barrell B. G. 1996; Analysis of the complete DNA sequence of murine cytomegalovirus. Journal of Virology 70:8833–8849
    [Google Scholar]
19. Reddehase M. J., Weiland F., Münch K., Jonjić S., Lüske A., Koszinowski U. H. 1985; Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. Journal of Virology 55:264–273
    [Google Scholar]
20. Reddehase M. J., Mutter W., Koszinowski U. H. 1987a; In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. Journal of Experimental Medicine 165:650–656
    [Google Scholar]
21. Reddehase M. J., Mutter W., Münch K., Bühring H. -J., Koszinowski U. H. 1987b; CD8-positive T lymphocytes specific for urine cytomegalovirus immediate-early antigens mediate protective immunity. Journal of Virology 67:3102–3108
    [Google Scholar]
22. Reddehase M. J., Jonjić S., Weiland F., Mutter W., Koszinowski U. H. 1988; Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host : CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. Journal of Virology 62:1061–1065
    [Google Scholar]
23. Reusser P., Riddell S. R., Meyers J. D., Greenberg P. D. 1991; Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373–1380
    [Google Scholar]
24. Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. 1992; Restoration of viral immunity in immuno- deficient humans by the adoptive transfer of T cell clones. Science 25:238–241
    [Google Scholar]
25. Salazar-Mather T. P., Orange S. J., Biron C. A. 1998; Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α(MIP-1α)-dependent pathways. Journal of Experimental Medicine 187:1–14
    [Google Scholar]
26. Steffens H. -P., Kurz S., Holtappels R., Reddehase M. J. 1998a; Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, andreduces therisk ofvirus recurrence. Journal of Virology 72:1797–1804
    [Google Scholar]
27. Steffens H. -P., Podlech J., Kurz S., Angele P., Dreis D., Reddehase M. J. 1998b; Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. Journal of Virology 72:5006–5015
    [Google Scholar]
28. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. 1995; Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine 333:1038–1044
    [Google Scholar]
29. Winston D. J., Ho W. G., Champlin R. E. 1990; Cytomegalovirus infections after bone marrow transplantation. Reviews ofInfectious Diseases 12:S776–S792
    [Google Scholar]